Search research articles
Contact Us
Filters
Showing results (361-370 of 390) with videos related to
Page
of 39
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
January 15, 2017
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences
Brian F Thomas, Timothy W Lefever, Ricardo A Cortes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 15, 2014
Identity-by-descent-guided mutation analysis and exome sequencing in consanguineous families reveals unusual clinical and molecular findings in retinal dystrophy
Frauke Coppieters, Kristof Van Schil, Miriam Bauwens, et al.
Oncogene
|
April 10, 2012
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
J H Schulte, S Lindner, A Bohrer, et al.
BMJ (Clinical Research Ed.)
|
September 4, 2004
Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial
Allen J Dietrich, Thomas E Oxman, John W Williams, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 16, 2017
Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies
Wenjun Zhang, Antony Hubbard, Tobin Jones, et al.
Plos One
|
October 8, 2011
Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics
Kim De Leeneer, Joachim De Schrijver, Lieven Clement, et al.
BMC Medicine
|
July 14, 2007
Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice
Richard T Hinkle, Frank R Lefever, Elizabeth T Dolan, et al.
Journal of Medicinal Chemistry
|
November 10, 2009
Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent
Jeroen C Verheijen, David J Richard, Kevin Curran, et al.
Scientific Reports
|
July 18, 2019
Author Correction: Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
Dries Rombaut, Hua-Sheng Chiu, Bieke Decaesteker, et al.
Scientific Reports
|
April 7, 2019
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
Dries Rombaut, Hua-Sheng Chiu, Bieke Decaesteker, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 390) with videos related to
Sort By:
Page
of 39
The Journal of Pharmacology and Experimental Therapeutics
|
January 15, 2017
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences
Brian F Thomas, Timothy W Lefever, Ricardo A Cortes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 15, 2014
Identity-by-descent-guided mutation analysis and exome sequencing in consanguineous families reveals unusual clinical and molecular findings in retinal dystrophy
Frauke Coppieters, Kristof Van Schil, Miriam Bauwens, et al.
Oncogene
|
April 10, 2012
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
J H Schulte, S Lindner, A Bohrer, et al.
BMJ (Clinical Research Ed.)
|
September 4, 2004
Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial
Allen J Dietrich, Thomas E Oxman, John W Williams, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
May 16, 2017
Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies
Wenjun Zhang, Antony Hubbard, Tobin Jones, et al.
Plos One
|
October 8, 2011
Practical tools to implement massive parallel pyrosequencing of PCR products in next generation molecular diagnostics
Kim De Leeneer, Joachim De Schrijver, Lieven Clement, et al.
BMC Medicine
|
July 14, 2007
Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice
Richard T Hinkle, Frank R Lefever, Elizabeth T Dolan, et al.
Journal of Medicinal Chemistry
|
November 10, 2009
Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent
Jeroen C Verheijen, David J Richard, Kevin Curran, et al.
Scientific Reports
|
July 18, 2019
Author Correction: Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
Dries Rombaut, Hua-Sheng Chiu, Bieke Decaesteker, et al.
Scientific Reports
|
April 7, 2019
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
Dries Rombaut, Hua-Sheng Chiu, Bieke Decaesteker, et al.
Page
of 39